Searching News Database: Vitoss
HSMN NewsFeed - 12 Jun 2018
NuVasive Launches AttraX Scaffold Biologic And Reports First Clinical Use
NuVasive Launches AttraX Scaffold Biologic And Reports First Clinical Use
HSMN NewsFeed - 16 May 2011
Orthovita, Inc. Agrees To Be Acquired by Stryker Corporation for $3.85 Per Share in Cash
Orthovita, Inc. Agrees To Be Acquired by Stryker Corporation for $3.85 Per Share in Cash
HSMN NewsFeed - 11 Feb 2011
Orthovita Receives FDA Clearance for Vitoss(TM) Bimodal Bone Graft Substitute
Orthovita Receives FDA Clearance for Vitoss(TM) Bimodal Bone Graft Substitute
HSMN NewsFeed - 7 Dec 2010
Orthovita Receives FDA Clearance for Vitoss(TM) Bioactive Foam-2X Bone Graft Substitute
Orthovita Receives FDA Clearance for Vitoss(TM) Bioactive Foam-2X Bone Graft Substitute
HSMN NewsFeed - 4 Oct 2010
Orthovita Receives FDA Clearance for VITOMATRIX(TM) Bone Graft Substitute in Dental Applications
Orthovita Receives FDA Clearance for VITOMATRIX(TM) Bone Graft Substitute in Dental Applications
HSMN NewsFeed - 6 Aug 2007
Orthovita Receives CE Mark for VITAGEL(R) Surgical Hemostat and CELLPAKER(R) Plasma Collection System
Orthovita Receives CE Mark for VITAGEL(R) Surgical Hemostat and CELLPAKER(R) Plasma Collection System
HSMN NewsFeed - 7 Feb 2007
Orthovita Announces Appointment of Chief Business Officer and Chief Financial Officer
Orthovita Announces Appointment of Chief Business Officer and Chief Financial Officer
HSMN NewsFeed - 12 Sep 2006
Albert J. Pavucek, Jr. Joins Orthovita as Vice President Corporate Controller
Albert J. Pavucek, Jr. Joins Orthovita as Vice President Corporate Controller
Additional items found! 45
Members Archive contains
45 additional stories matching:
Vitoss
(Password required)
Vitoss
(Password required)